Navigation Links
Amgen Announces PDUFA Date for XGEVA® Supplemental Biologics License Application
Date:8/22/2011

compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo:  http://photos.prnewswire.com
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Governor Tom Wolf announced today that ... markets implants in the spine and trauma markets, will establish ... Northampton County to serve as its ... 25 new, full-time jobs. "Tyber Medical,s decision ... more than two dozen, high-paying jobs is great news for ...
(Date:8/4/2015)... 2015 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... and Chief Executive Officer, Doug Godshall , is ... Growth Conference at 8:30 a.m. EDT on Thursday, August ... 2015 at the InterContinental Boston. A live ...
(Date:8/4/2015)... -- The Pittsburgh Life Sciences Greenhouse (PLSG), the region,s only ... of its portfolio companies, Medrobotics Corporation, has received FDA ... System in the U.S.  "I couldn,t ... John W. Manzetti , president and CEO of ... spinning out of The Robotics Institute at Carnegie Mellon ...
Breaking Medicine Technology:Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 2Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 3HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3
... and NEW YORK, Nov. 9, 2010 ... ACCP ), a biopharmaceutical company leveraging its proprietary drug-delivery ... care and diabetes, announced today that its Chairman, Steven Rouhandeh, ... Investors Conference on Friday, November 12, 2010, at 1:00 pm ...
... Nov. 9, 2010 MonoSol Rx, the ... delivery company specializing in proprietary pharmaceutical film products, today ... 7,824,588 from the United States Patent and Trademark Office ... intellectual property protection for the Company,s film products and ...
Cached Medicine Technology:Access Pharmaceuticals to Present at LifeTech Capital Miami Medical Investors Conference on November 12th 2MonoSol Rx Issued Strategic U.S. Patent Governing the Manufacturing of Pharmaceutical Films 2MonoSol Rx Issued Strategic U.S. Patent Governing the Manufacturing of Pharmaceutical Films 3
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... information, checking with “Dr. Google” before calling a physician. In an effort to ... the first health care provider in Pennsylvania to publicly share patient satisfaction ratings ...
(Date:8/4/2015)... ... 04, 2015 , ... NutraScience Labs , a world-class ... joined over 200 other Long Island-based corporations as participants in the 10th annual ... Jones Beach State Park in Wantagh, New York. , According to Mindy Davidson, ...
(Date:8/4/2015)... ... August 04, 2015 , ... Patients are ... offered by the world renowned Beverly Hills facelift surgeon , Dr. Paul ... surgery techniques helps individuals to achieve an outer appearance that meets their personal ...
(Date:8/4/2015)... ... August 04, 2015 , ... Montclair State University and Atlantic Health ... of its kind in New Jersey, which starting this Fall will help prepare those ... School partnered with Atlantic Health System, one of the largest health care organizations in ...
(Date:8/4/2015)... ... August 04, 2015 , ... Providigm, LLC, a developer of ... announced details of the Advanced level of their national accreditation for Quality Assurance ... Accreditation program , introduced in 2013, is based on standards for excellence in ...
Breaking Medicine News(10 mins):Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3
... as sprain or muscle rupture raised venous thrombosis odds, study ... injures -- including ankle sprains and muscle ruptures -- ... or lungs, suggests a study by researchers in the Netherlands. ... treatments such as surgery, a plaster cast, and extended bed ...
... of the largest studies yet of Alzheimers disease ... researchers at Mayo Clinic Jacksonville have found strong ... risk factor APOE4 influence who is at risk ... , Studying 25 multigenerational families of individuals diagnosed ...
... a human-pathogenic virus which belongs to the herpes virus ... infestation rate of more than 90 %, EBV is ... genome consists of double-stranded DNA, and it is one ... humans under certain circumstances. EBV-associated cancers include lymphomas (cancer ...
... are sometimes unable to carry out their relatives wish to ... making a gift of life and protecting the body of ... Advanced Nursing. , Researchers from the University of Southampton, UK, ... their relatives bodies be used for organ donations about their ...
... the increase , , THURSDAY, Jan. 17 (HealthDay News) -- ... in three decades, according to a new report released ... Rachel Jones, senior research associate at the Guttmacher Institute, ... findings will be published in the March issue of ...
... ... - Multi-year collaboration for NLP-based literature search and ... Linguamatics,Ltd, the leader in natural language processing (NLP) for life ... an affiliate of the Medical Knowledge Group (MKG), announce a,multi-year ...
Cached Medicine News:Health News:Minor Leg Injuries Might Boost Blood Clot Risk 2Health News:Evidence found for genes that affect risk of developing Alzheimer's disease 2Health News:Evidence found for genes that affect risk of developing Alzheimer's disease 3Health News:Evidence found for genes that affect risk of developing Alzheimer's disease 4Health News:A tricky tumor virus 2Health News:Relatives who decline organ donations face conflict and guilt 2Health News:Relatives who decline organ donations face conflict and guilt 3Health News:U.S. Abortion Rate Falls to Lowest Level in Decades 2Health News:U.S. Abortion Rate Falls to Lowest Level in Decades 3Health News:Linguamatics and 81qd Sign Multi-Year Collaboration in Knowledge Discovery for Product Life Cycle Management 2Health News:Linguamatics and 81qd Sign Multi-Year Collaboration in Knowledge Discovery for Product Life Cycle Management 3Health News:Linguamatics and 81qd Sign Multi-Year Collaboration in Knowledge Discovery for Product Life Cycle Management 4
... Healon is a sterile, nonpyrogenic, viscoelastic ... high molecular weight fraction of sodium ... sodium hyaluronate dissolved in physiological sodium ... high molecular weight polymer is made ...
... fiscal year 2004, Biomet plans to ... to the global market, enhancing visualization ... Acumen technology was developed in conjunction ... based in Hollywood, Florida. Procedure-specific software ...
... response and eye movement is an important ... because eye movements and pupil responses are ... visual neuronal centers and pathways that are ... Analyzer (VPA) provides pre-programmed visual stimuli and ...
From the initial viewing screen through the completion of the exam the ADIS-9000 has been designed for ease of use and intuitive operation. The built-in software simplifies patient reporting, image s...
Medicine Products: